Back to News
Market Impact: 0.15

Pacira BioSciences Announces Publication of Positive Two-Year Phase 1 Data For PCRX-201 in Annals of the Rheumatic Diseases

Healthcare & BiotechCompany Fundamentals

PCRX-201 showed good tolerability after a single locally administered intra-articular knee injection in patients with moderate-to-severe knee osteoarthritis. The report does not provide efficacy or adverse-event rates, but the safety/acceptability signal is positive for clinical development.

Analysis

PCRX-201 showed good tolerability after a single locally administered intra-articular knee injection in patients with moderate-to-severe knee osteoarthritis. The report does not provide efficacy or adverse-event rates, but the safety/acceptability signal is positive for clinical development.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request Demo

Market Sentiment

Overall Sentiment

mildly positive

Sentiment Score

0.15

More News